FDAsafety guidance66% confidence
FDA AP — OXYCODONE HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Sciegen Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA206456. Sponsor: PHARMOBEDIENT. Submission status: AP. Submission type: SUPPL. Active ingredients: OXYCODONE HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Psychiatry · Antidepressant
- Sub-indication
- General
Related signal: FDA Accepts Supplement for Fluoxetine Hydrochloride by Sciegen Pharmaceuticals